chartexchange

RXST
RxSight, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
5.01USD+3.727%(+0.18)736,094
After-hoursNov 18, 2026 4:00:30 PM EST
5.01USD0.000%(-0.00)
Loading…
Loading…
209.86M
Healthcare
Medical Devices
HQ
Aliso Viejo, CA, USA
Previous Close
$4.83
Beta
1.36
52-Week High
$13.22 2025-12-11
52-Week Low
$4.11 2026-11-04
SMA 50
$4.99
SMA 200
$6.10
Avg. Vol 10D
1.25M
Avg. Vol 30D
879,313
Avg. Vol 90D
870,290
Relative Vol
0.84
38.89M
0.2900%
1,700,000
1,142
RXST Profile

calhoun vision is the world leader in adjustable intraocular lens technology. the company's proprietary technology utilizes light to enable surgeons to change the power of a lens after it has been implanted in the eye. this offers the potential to provide unparalleled visual outcomes and customization to the specific visual needs of each patient. calhoun vision's light adjustable lens technology is an investigational device in the united states and requires fda approval before it can be marketed commercially. the company has completed phases i and ii of the required clinical investigation; the third and final phase of study has commenced, and all subjects have been fully enrolled.

RXST Performance
PeriodPriceDateChangeBeta
1W5.282026-11-11-5.21%1.074
1M4.692026-10-19+6.72%2.279
3M6.372026-08-18-21.43%1.720
6M6.002026-05-18-16.58%0.969
1Y9.602025-11-18-47.87%1.361
2Y44.662024-11-18-88.79%—
5Y12.802021-11-18-60.90%1.254
RXST Stock Summary

RxSight, Inc. Common Stock (NASDAQ:RXST) stock price today is $5.01, and today's volume is 736,094. RXST is up 3.623% today. The 30 day average volume is 879,313. RXST market cap is $209.86M with 41.93M shares outstanding.